Cubist pharmaceuticals stock price
WebApr 6, 2024 · Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) issued its quarterly earnings results on Tuesday, February, 28th. The company reported $0.06 EPS for the quarter, topping the consensus estimate of ($0.24) by $0.30. The company had revenue of $61.88 million for the quarter, compared to analysts' expectations of $47.18 million. WebCubist Pharmaceuticals Stock Price, Funding, Valuation, Revenue & Financial Statements Cubist Pharmaceuticals Unclaimed cubist.com Claim your profile to get in front of buyers, investors, and analysts. Submit Your Analyst Briefing Analyst Briefing Submitters are 7x more likely to receive a qualified connection. Learn more. Overview & …
Cubist pharmaceuticals stock price
Did you know?
WebFeb 11, 2014 · Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Cubist Pharmaceuticals, Inc. (CBSTZ) … WebCBST (CBST) has the following price history information. Looking back at CBST historical stock prices for the last five trading days, on January 14, 2015, CBST opened at …
WebApr 9, 2024 · Cantor Fitzgerald upped their target price on shares of ACADIA Pharmaceuticals from $28.00 to $33.00 and gave the stock an “overweight” rating in a research report on Tuesday, March 14th. WebApr 6, 2024 · 14 brokers have issued 1 year price objectives for Apellis Pharmaceuticals' shares. Their APLS share price forecasts range from $40.00 to $139.00. On average, they predict the company's share price to reach $78.40 in the next twelve months. This suggests that the stock has a possible downside of 0.5%.
WebSep 5, 2013 · Cubist Pharmaceuticals, Inc. today announced the pricing of $700 million aggregate principal amount of convertible senior unsecured notes that will be issued in … WebJun 30, 2014 · Trius was a stock which I first recommended in May of 2012, a little over one year before it was taken over by Cubist. In a series of reports that are available on my website, I projected that Sivextro could achieve worldwide sales of $1 billion in 2024.
WebJun 30, 2014 · Trius was a stock which I first recommended in May of 2012, a little over one year before it was taken over by Cubist. In a series of reports that are available on my …
WebApr 14, 2024 · RadNet, Inc. (NASDAQ:RDNT – Get Rating)’s share price reached a new 52-week high on Wednesday . The stock traded as high as $27.59 and last traded at $27.35, with a volume of 15491 shares ... nanachi twitterWebJan 21, 2015 · Merck announced the successful completion of the tender offer for all of the outstanding shares of common stock of Cubist Pharmaceuticals, Inc. at a purchase price of $102.00 per share. Contacts megan fox thierry mugler dressWebA. ANTIVENIN™ (LATRODECTUS MACTANS) B. BCG Vaccine (For Percutaneous Use) BELSOMRA® (suvorexant) tablets, for oral use, C-IV. BRIDION® (sugammadex) Injection, for intravenous use. C. CANCIDAS® (caspofungin acetate) for Injection, for intravenous use. CUBICIN® (daptomycin for injection) for Intravenous Use. megan fox then and now picsWebJan 9, 2015 · Cubist Pharmaceuticals shoots to the moon after a big pharma rival agreed to purchase it for a hefty premium. Why Cubist Pharmaceuticals Inc. Stock … megan fox then and nowWebJan 21, 2015 · outstanding shares of common stock of Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) at a purchase price of $102.00 per share. As of the tender offer … nanachi soundsWebCubist Pharmaceuticals Inc. share price - Stocktwits is the best way to find out what is happening right now around the CBST stock and other stock companies and markets. nanachi x bondrewdWebApr 9, 2024 · The stock was sold at an average price of $4.83, for a total value of $172,498.62. Following the transaction, the director now owns 783,965 shares in the company, valued at approximately ... nanachi ref sheet